Multiple Sclerosis
1 - 15 of
43 Results
Sort Results:
Article:
Lemtrada (LEM-trah-dah, alemtuzumab) will be a new IV option for relapsing-remitting forms of multiple sclerosis (MS)
June 2014
Article:
Aubagio (oh-BAH-gee-oh, teriflunomide), the third ORAL option for relapsing forms of multiple sclerosis (MS)
February 2014
Article:
the second ORAL drug for relapsing-remitting multiple sclerosis (MS), Tecfidera (TEK-fi-de-rah, dimethyl fumarate)
June 2013